Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × X-Rays × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

OTHER 20 NIH 13 NETWORK 2 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Head & Neck 1 Gastrointestinal 1 Breast 1

Conditions

Barrett Esophagus 1

Interventions

Gemcitabine 252 Fluorouracil 233 Oxaliplatin 216 Bevacizumab 214 Capecitabine 186 pembrolizumab 179 Leucovorin 179 Irinotecan 152 Cisplatin 123 Cetuximab 117 Nivolumab 106 Paclitaxel 94 130-nm albumin-bound paclitaxel 92 Sorafenib 74 Docetaxel 58 Albumin-Bound Paclitaxel 57 Folfox protocol 54 atezolizumab 52 IFL protocol 52 regorafenib 47 durvalumab 38 Trastuzumab 38 Panitumumab 38 Sunitinib 37 Ramucirumab 37 Injections 36 Drug Therapy 35 Carboplatin 34 Cyclophosphamide 32 tislelizumab 30

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01209013 2012-05-08

Oedisse

Pinnacle Biologics Inc.

Phase 3 Withdrawn

Gastrointestinal

Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡